adamfeuerstein

Joined Jan 05, 2010

Bio: Sr. Columnist at TheStreet. I cover biotech and drug stocks. I'm a skeptic, RT stuff I disagree with and use naughty words. Deal with it.

adamfeuerstein
$SGEN reports Q4 EPS on Monday. My best guess is Adcetris revenue consensus is in low $30Ms. Tough to pinpoint exactly.

Feb. 10 at 11:37 AM

from Twitter
adamfeuerstein
$SOMX - Roth Capital downgrades to neutral from buy. Thanks guys, great call!

Feb. 10 at 8:02 AM

from Twitter
adamfeuerstein
One year go, $EXEL raised money at $11/shr. Last night, raised money at $5.50/shr. Wrong direction, guys...

Feb. 10 at 7:49 AM

from Twitter
adamfeuerstein
This week's Biotech Stock Mailbag --> http://t.co/JTXrv4jY Why $CORT's Korlym will be rejected + answers to $ONTY ?s from @given2tweet.

Feb. 10 at 7:31 AM

from Twitter
adamfeuerstein
$OSIR CEO Randy Mills is dog shit $SNY CEO Chris Viehbacher wiped off his shoe. Good luck Randy trying to get someone else to step in it.

Feb. 9 at 7:39 PM

from Twitter
adamfeuerstein
RT @aafiac: $ASTX Has Dacogen demonstrated risk benefit for new AML >65yrs non induction Yes3 No10 ABstain1

Feb. 9 at 12:33 PM

from Twitter
adamfeuerstein
$BIIB denying Biopharm Insignt story about BG-12 NDA filing delay due to side effect issue (h/t @MarkSchoenebaum)

Feb. 9 at 12:12 PM

from Twitter
adamfeuerstein
It's been 32 hrs since $SNY annc'd dropping Prochymal for GVHD. Any guesses how long it will take $OSIR to comment publicly?

Feb. 9 at 10:11 AM

from Twitter
adamfeuerstein
$OSIR -- $SNY dropped the Prochymal GVHD program. Disclosed by $SNY yesterday in Q4 report but $OSIR has said nothing so far. Typical.

Feb. 9 at 9:51 AM

from Twitter
adamfeuerstein
Ray Dirks was paid $4,000 to write this hagiography of $CVM --> http://t.co/ScXdDMac How much are the Russian spokesmodels paid?

Feb. 9 at 8:29 AM

from Twitter
adamfeuerstein
@JNapodano $BPAX strategy is to maintain cushy exec salaries as long as possible, so in that context, Libigel safety study makes sense.

Feb. 9 at 8:04 AM

from Twitter
adamfeuerstein
$BPAX says Libigel placebo is safe. Well, lordy lord, ain't that encouraging.

Feb. 9 at 7:59 AM

from Twitter
adamfeuerstein
$APRI selling stock.. you just knew this was coming

Feb. 8 at 4:07 PM

from Twitter
adamfeuerstein
$AMGN - the negative FDA panel vote on #Xgeva was expected. Most analysts don't have bone mets prevention sales in their forecasts.

Feb. 8 at 12:11 PM

from Twitter
adamfeuerstein
RT @aafiac: As expected $AMGN #Xgeva vote: Has it demonstrated favorable risk benefit in CRPC pre met Yes:1 No:12 Abstain:0

Feb. 8 at 12:09 PM

from Twitter
adamfeuerstein
$AMGN FDA panel on #Xgeva is voting. I'm following @RPMReportMike for the play by play.

Feb. 8 at 12:07 PM

from Twitter

Follow investors and traders who match your style.
Interact with a deep investing community.
Journal your ideas - the best investors do!

StockTwits View profile on Twitter

Badges

Suggested

adamfeuerstein

Join StockTwits Today!

Badges

Sign in to StockTwits X

New to StockTwits?

Sign up for real time news, charts, and ideas on the stocks you care about.